Articles dans des revues avec comité de lecture (24)
  1. 1. Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J. H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., Baumann, P. S., Klauser, P., Conus, P., Tirouvanziam, R., Cuenod, M., & Do, K. K. (2020). MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Molecular psychiatry, 25(11), 3105. doi:10.1038/s41380-019-0393-5
  2. 2. Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J. H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., Baumann, P. S., Klauser, P., Conus, P., Tirouvanziam, R., Cuenod, M., & Do, K. K. (2020). Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Molecular psychiatry. doi:10.1038/s41380-020-0716-6
  3. 3. Liu, S., Blesch, A., Sandner, B., Schackel, T., Nicholson, L. S., Chtarto, A., Tenenbaum, L., Puttagunta, R., Müller, R., & Weidner, N. (2017). Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury. Acta Biomaterialia, 60, 167-180. doi:10.1016/j.actbio.2017.07.024
  4. 4. Bazewicz, M., Draganova, D., Makhoul, M., Chtarto, A., Elmaleh, V., Tenenbaum, L., Caspers, L., Bruyns, C., & Willermain, F. (2016). Effect of SOCS1 overexpression on RPE cell activation by proinflammatory cytokines. Neuroscience letters, 630, 209-215. doi:10.1016/j.neulet.2016.07.054
  5. 5. Barroso-Chinea, P., González-Hernández, T., Cruz-Muros, I., Afonso-Oramas, D., Castro-Hernández, J., Salas-Hernández, J., Chtarto, A., Luis-Ravelo, D., Humbert-Claude, M., & Tenenbaum, L. (2016). Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system. Neurobiology of disease, 88, 44-54. doi:10.1016/j.nbd.2016.01.002
  6. 6. Chtarto, A., Humbert-Claude, M., Bockstael, O., Das, A. A., Boutry, S., Breger, L. L., Klaver, B., Melas, C., Barroso-Chinea, P., González-Hernández, T., Muller, R. N., De Witte, O., Levivier, M., Lundberg, C., Berkhout, B., & Tenenbaum, L. (2016). A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular therapy. Methods & clinical development, 5, 16027. doi:10.1038/mtm.2016.27
  7. 7. Bockstael, O., Tenenbaum, L., Dalkara, D., Melas, C., De Witte, O., Levivier, M., & Chtarto, A. (2014). Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional  euroinflammation induced by systemic kainic acid treatment. Frontiers in Molecular Neuroscience, 7(DEC), 92. doi:10.3389/fnmol.2014.00092
  8. 8. Ayuso, E., Leon, X., Bosch, F., Blouin, V., Darmon, C., Moullier, P., Lock, M., Alvira, M. M., McGorray, S., Auricchio, A., Doria, M., Bucher, S., Chtarto, A., Melas, C., Bockstael, O., Clark, R. K., Fountain, W., Gao, G., Gao, K., Giacca, M., Zentilin, L., Kleinschmidt, J., Leuchs, B., Müller, M., Mizukami, H., Ozawa, K., Noordman, Y., Van Der Linden, I., Pythoud, C., Tenenbaum, L., Sumaroka, M., Wright, J. F., Zhang, X., Surosky, R., Weins, B., & Snyder, R. O. (2014). Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Human gene therapy, 25(11), 977-987. doi:10.1089/hum.2014.057
  9. 9. Chtarto, A., Bockstael, O., Tshibangu, T., De Witte, O., Levivier, M., & Tenenbaum, L. (2013). A next step in adeno-associated virus-mediated gene therapy for neurological diseases: Regulation and targeting. British journal of clinical pharmacology, 76(2), 217-232. doi:10.1111/bcp.12065
  10. 10. Chtarto, A., Bockstael, O., Gebara, E., Vermoesen, K., Melas, C., Pythoud, C., Levivier, M., De Witte, O., Luthi-Carter, R., Clinkers, R., & Tenenbaum, L. (2013). An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-κB Activation for Disease-Inducible Gene Transfer. PloS one, 8(1), e53156. doi:10.1371/journal.pone.0053156
  11. 11. Vanrell, L., Di Scala, M., Blanco, L., Otano, I., Gil-Farina, I., Baldim, V., Paneda, A., Berraondo, P., Beattie, S., Chtarto, A., Tenenbaum, L., Prieto, J., & Gonzalez-Aseguinolaza, G. (2011). Development of a liver-specific tet-on inducible system for AAV vectors and its application in the treatment of liver cancer. Molecular therapy, 19(7), 1245-1253. doi:10.1038/mt.2011.37
  12. 12. Lock, M., McGorray, S., Auricchio, A., Ayuso, E., Beecham, E. J., Blouin, V., Bosch, F., Bose, M., Byrne, B., Caton, T., Chiorini, J. A., Chtarto, A., Clark, K. R., Conlon, T., Darmon, C., Doria, M., Douar, A.-M., Flotte, T. R., Francis, J., Francois, A., Giacca, M., Korn, M., Korytov, I., Leon, X., Leuchs, B., Lux, G., Melas, C., Mizukami, H., Moullier, P., Muller, M., Ozawa, K., Philipsberg, T., Poulard, K., Raupp, C., Riviere, C., Roosendaal, S., Samulski, R. J., Soltys, S., Surosky, R. T., Tenenbaum, L., Thomas, D. L., van Montfort, B., Veres, G., Wright, J. F., Xu, Y., Zelenaia, O., Zentilin, L., & Snyder, R. O. (2010). Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material. Human gene therapy. doi:10.1089/hum.2009.223
    13. << Précédent 1 2 3 Suivant >>